Clinical Trials Browser

Phase 2 × Thymic epithelial tumor × apatinib × Clear all

NCT06200233 2024-04-09

Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor

Phase 2 Not yet recruiting

Thymic epithelial tumor